FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:IL1RAPL1-DMD

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: IL1RAPL1-DMD
FusionPDB ID: 39469
FusionGDB2.0 ID: 39469
HgeneTgene
Gene symbol

IL1RAPL1

DMD

Gene ID

11141

1756

Gene nameinterleukin 1 receptor accessory protein like 1dystrophin
SynonymsIL-1-RAPL-1|IL-1RAPL-1|IL1R8|IL1RAPL|IL1RAPL-1|MRX10|MRX21|MRX34|OPHN4|TIGIRR-2BMD|CMD3B|DXS142|DXS164|DXS206|DXS230|DXS239|DXS268|DXS269|DXS270|DXS272|MRX85
Cytomap

Xp21.3-p21.2

Xp21.2-p21.1

Type of geneprotein-codingprotein-coding
Descriptioninterleukin-1 receptor accessory protein-like 1X-linked interleukin-1 receptor accessory protein-like 1interleukin 1 receptor-8mental retardation, X-linked 10oligophrenin-4three immunoglobulin domain-containing IL-1 receptor-related 2dystrophin
Modification date2020031320200329
UniProtAcc

Q9NZN1

Main function of 5'-partner protein: FUNCTION: May regulate secretion and presynaptic differentiation through inhibition of the activity of N-type voltage-gated calcium channel (PubMed:12783849). May activate the MAP kinase JNK (PubMed:15123616). Plays a role in neurite outgrowth (By similarity). During dendritic spine formation can bidirectionally induce pre- and post-synaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity). {ECO:0000250|UniProtKB:P59823, ECO:0000250|UniProtKB:P59824, ECO:0000269|PubMed:12783849, ECO:0000269|PubMed:15123616}.

P11532

Main function of 5'-partner protein: FUNCTION: Anchors the extracellular matrix to the cytoskeleton via F-actin. Ligand for dystroglycan. Component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction (NMJ) and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. Also implicated in signaling events and synaptic transmission. {ECO:0000250|UniProtKB:P11531, ECO:0000269|PubMed:16710609}.
Ensembl transtripts involved in fusion geneENST idsENST00000302196, ENST00000378993, 
ENST00000288447, ENST00000361471, 
ENST00000378680, ENST00000378702, 
ENST00000378723, ENST00000445312, 
ENST00000343523, ENST00000357033, 
ENST00000359836, ENST00000378677, 
ENST00000378707, ENST00000474231, 
ENST00000541735, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score11 X 12 X 4=52835 X 39 X 12=16380
# samples 1241
** MAII scorelog2(12/528*10)=-2.13750352374993
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(41/16380*10)=-5.32016763702292
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: IL1RAPL1 [Title/Abstract] AND DMD [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: IL1RAPL1 [Title/Abstract] AND DMD [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)IL1RAPL1(29417425)-DMD(31697705), # samples:1
Anticipated loss of major functional domain due to fusion event.IL1RAPL1-DMD seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
IL1RAPL1-DMD seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
IL1RAPL1-DMD seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
IL1RAPL1-DMD seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneIL1RAPL1

GO:0045920

negative regulation of exocytosis

12783849

HgeneIL1RAPL1

GO:0099175

regulation of postsynapse organization

21926414

HgeneIL1RAPL1

GO:0099545

trans-synaptic signaling by trans-synaptic complex

21926414

HgeneIL1RAPL1

GO:1905606

regulation of presynapse assembly

21926414

TgeneDMD

GO:0043043

peptide biosynthetic process

16000376



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chrX:29417425/chrX:31697705)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across IL1RAPL1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across DMD (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000378993IL1RAPL1chrX29417425+ENST00000378707DMDchrX31697705-7465137664047731377
ENST00000378993IL1RAPL1chrX29417425+ENST00000359836DMDchrX31697705-7394137664047881382
ENST00000378993IL1RAPL1chrX29417425+ENST00000541735DMDchrX31697705-7135137664044431267
ENST00000378993IL1RAPL1chrX29417425+ENST00000343523DMDchrX31697705-7103137664044971285
ENST00000378993IL1RAPL1chrX29417425+ENST00000378677DMDchrX31697705-7465137664047731377
ENST00000378993IL1RAPL1chrX29417425+ENST00000357033DMDchrX31697705-7465137664047731377
ENST00000378993IL1RAPL1chrX29417425+ENST00000474231DMDchrX31697705-5264137664048271395
ENST00000302196IL1RAPL1chrX29417425+ENST00000378707DMDchrX31697705-6792703041001366
ENST00000302196IL1RAPL1chrX29417425+ENST00000359836DMDchrX31697705-6721703041151371
ENST00000302196IL1RAPL1chrX29417425+ENST00000541735DMDchrX31697705-6462703037701256
ENST00000302196IL1RAPL1chrX29417425+ENST00000343523DMDchrX31697705-6430703038241274
ENST00000302196IL1RAPL1chrX29417425+ENST00000378677DMDchrX31697705-6792703041001366
ENST00000302196IL1RAPL1chrX29417425+ENST00000357033DMDchrX31697705-6792703041001366
ENST00000302196IL1RAPL1chrX29417425+ENST00000474231DMDchrX31697705-4591703041541384

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000378993ENST00000378707IL1RAPL1chrX29417425+DMDchrX31697705-0.0004874320.99951255
ENST00000378993ENST00000359836IL1RAPL1chrX29417425+DMDchrX31697705-0.0003066740.9996934
ENST00000378993ENST00000541735IL1RAPL1chrX29417425+DMDchrX31697705-0.000432560.99956745
ENST00000378993ENST00000343523IL1RAPL1chrX29417425+DMDchrX31697705-0.0004696840.9995303
ENST00000378993ENST00000378677IL1RAPL1chrX29417425+DMDchrX31697705-0.0004874320.99951255
ENST00000378993ENST00000357033IL1RAPL1chrX29417425+DMDchrX31697705-0.0004874320.99951255
ENST00000378993ENST00000474231IL1RAPL1chrX29417425+DMDchrX31697705-0.002440360.99755967
ENST00000302196ENST00000378707IL1RAPL1chrX29417425+DMDchrX31697705-0.0002587730.99974126
ENST00000302196ENST00000359836IL1RAPL1chrX29417425+DMDchrX31697705-0.0001663130.9998337
ENST00000302196ENST00000541735IL1RAPL1chrX29417425+DMDchrX31697705-0.0002191870.99978083
ENST00000302196ENST00000343523IL1RAPL1chrX29417425+DMDchrX31697705-0.0002403690.9997596
ENST00000302196ENST00000378677IL1RAPL1chrX29417425+DMDchrX31697705-0.0002587730.99974126
ENST00000302196ENST00000357033IL1RAPL1chrX29417425+DMDchrX31697705-0.0002587730.99974126
ENST00000302196ENST00000474231IL1RAPL1chrX29417425+DMDchrX31697705-0.001564590.99843544

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for IL1RAPL1-DMD

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
IL1RAPL1chrX29417425DMDchrX316977051376245GFVVRRTTELTVTVERIQNQWDEVQE
IL1RAPL1chrX29417425DMDchrX31697705703234GFVVRRTTELTVTVERIQNQWDEVQE

Top

Potential FusionNeoAntigen Information of IL1RAPL1-DMD in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
IL1RAPL1-DMD_29417425_31697705.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:38RTTELTVTV0.99660.6966514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:01TVERIQNQW0.99550.98121221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A30:08RTTELTVTV0.99430.814514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:21RTTELTVTV0.99370.6894514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:04RTTELTVTV0.99290.7545514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:35RTTELTVTV0.99210.5794514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:22RTTELTVTV0.99190.5054514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:60RTTELTVTV0.99140.6079514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:67RTTELTVTV0.99130.5742514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:30RTTELTVTV0.99130.5742514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:24RTTELTVTV0.99130.5742514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:11RTTELTVTV0.99110.5886514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:13RTTELTVTV0.99060.6843514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:20RTTELTVTV0.99030.5735514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:29RTTELTVTV0.98920.57514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:27RTTELTVTV0.98810.6057514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B15:16RTTELTVTV0.9870.9516514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B58:02TVERIQNQW0.98410.97091221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B58:01TVERIQNQW0.98380.97291221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A32:13RTTELTVTV0.96160.9363514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B15:17TVERIQNQW0.9370.93281221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:03TVERIQNQW0.85510.98981221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B13:02RTTELTVTV0.7990.9069514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B53:01TVERIQNQW0.78040.66861221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A32:13TVERIQNQW0.76680.9511221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B52:01RTTELTVTV0.16070.9803514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:01VTVERIQNQW0.99990.98451121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B27:04RRTTELTVTV0.99980.6395414
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B27:07RRTTELTVTV0.99970.6532414
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B58:02VTVERIQNQW0.99960.96061121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B58:01VTVERIQNQW0.99910.97571121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:03VTVERIQNQW0.99770.99261121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B15:17VTVERIQNQW0.99730.90171121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B15:16VTVERIQNQW0.99270.95251121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A32:13VTVERIQNQW0.86930.96541121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A34:02TTELTVTVER0.61230.5188616
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:01TVTVERIQNQW0.99990.98031021
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B58:01TVTVERIQNQW0.99810.9721021
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A74:03RTTELTVTVER0.99590.57516
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A74:11RTTELTVTVER0.99590.57516
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A74:09RTTELTVTVER0.99590.57516
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A31:02RTTELTVTVER0.99070.5892516
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C15:06RTTELTVTV0.99980.8827514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C15:04RTTELTVTV0.99970.8908514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C04:06RTTELTVTV0.99970.967514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:01RTTELTVTV0.99130.5742514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C06:03RTTELTVTV0.98150.9896514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C12:04RTTELTVTV0.98070.9875514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C02:06RTTELTVTV0.97560.9708514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B44:08TVERIQNQW0.3290.6361221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B27:14RRTTELTVTV0.99990.5297414
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A31:01RTTELTVTVER0.9960.5302516
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C15:02RTTELTVTV0.99990.8824514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C15:05RTTELTVTV0.99980.9231514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C15:09RTTELTVTV0.99970.8908514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C16:02RTTELTVTV0.99860.9908514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:10TVERIQNQW0.99550.98121221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:14RTTELTVTV0.99380.6142514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A02:06RTTELTVTV0.99370.6894514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A68:02RTTELTVTV0.98920.6262514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A32:01RTTELTVTV0.98670.9702514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:04TVERIQNQW0.98560.82211221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:02RTTELTVTV0.97880.9352514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A69:01RTTELTVTV0.97450.7542514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C16:04RTTELTVTV0.96320.9661514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B58:06TVERIQNQW0.96220.97491221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C12:03RTTELTVTV0.95210.9721514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-C17:01RTTELTVTV0.9340.9765514
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:02TVERIQNQW0.88350.97891221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A32:01TVERIQNQW0.86060.97451221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B15:13TVERIQNQW0.81180.95361221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B18:06TELTVTVER0.80410.8817716
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B53:02TVERIQNQW0.62470.67911221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A25:01TVERIQNQW0.36240.9251221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B15:24TVERIQNQW0.11750.97281221
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:10VTVERIQNQW0.99990.98451121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:04VTVERIQNQW0.99970.76251121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B27:06RRTTELTVTV0.99970.7083414
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B58:06VTVERIQNQW0.9990.97481121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:02VTVERIQNQW0.99570.96921121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A32:01VTVERIQNQW0.95890.9741121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B15:24VTVERIQNQW0.89080.96591121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A25:01VTVERIQNQW0.39570.90741121
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:10TVTVERIQNQW0.99990.98031021
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:04TVTVERIQNQW0.99950.79971021
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-A74:01RTTELTVTVER0.99590.57516
IL1RAPL1-DMDchrX29417425chrX31697705703HLA-B57:02TVTVERIQNQW0.99570.97451021

Top

Potential FusionNeoAntigen Information of IL1RAPL1-DMD in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
IL1RAPL1-DMD_29417425_31697705.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
IL1RAPL1-DMDchrX29417425chrX31697705703DRB1-0411TVTVERIQNQWDEVQ1025
IL1RAPL1-DMDchrX29417425chrX31697705703DRB1-0411LTVTVERIQNQWDEV924
IL1RAPL1-DMDchrX29417425chrX31697705703DRB1-0467TVTVERIQNQWDEVQ1025
IL1RAPL1-DMDchrX29417425chrX31697705703DRB1-0491TVTVERIQNQWDEVQ1025
IL1RAPL1-DMDchrX29417425chrX31697705703DRB1-0491LTVTVERIQNQWDEV924

Top

Fusion breakpoint peptide structures of IL1RAPL1-DMD

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
9686TTELTVTVERIQNQIL1RAPL1DMDchrX29417425chrX31697705703

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of IL1RAPL1-DMD

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN9686TTELTVTVERIQNQ-7.9962-8.1096
HLA-B14:023BVN9686TTELTVTVERIQNQ-5.70842-6.74372
HLA-B52:013W399686TTELTVTVERIQNQ-6.83737-6.95077
HLA-B52:013W399686TTELTVTVERIQNQ-4.4836-5.5189
HLA-A11:014UQ29686TTELTVTVERIQNQ-10.0067-10.1201
HLA-A11:014UQ29686TTELTVTVERIQNQ-9.03915-10.0745
HLA-A24:025HGA9686TTELTVTVERIQNQ-6.56204-6.67544
HLA-A24:025HGA9686TTELTVTVERIQNQ-5.42271-6.45801
HLA-B44:053DX89686TTELTVTVERIQNQ-7.85648-8.89178
HLA-B44:053DX89686TTELTVTVERIQNQ-5.3978-5.5112
HLA-A02:016TDR9686TTELTVTVERIQNQ-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of IL1RAPL1-DMD

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
IL1RAPL1-DMDchrX29417425chrX316977051021TVTVERIQNQWCTGTTACAGTTGAAAGAATTCAGAATCAGTGGG
IL1RAPL1-DMDchrX29417425chrX316977051121VTVERIQNQWTTACAGTTGAAAGAATTCAGAATCAGTGGG
IL1RAPL1-DMDchrX29417425chrX316977051221TVERIQNQWCAGTTGAAAGAATTCAGAATCAGTGGG
IL1RAPL1-DMDchrX29417425chrX31697705414RRTTELTVTVGAAGAACTACTGAATTAACTGTTACAGTTG
IL1RAPL1-DMDchrX29417425chrX31697705514RTTELTVTVGAACTACTGAATTAACTGTTACAGTTG
IL1RAPL1-DMDchrX29417425chrX31697705516RTTELTVTVERGAACTACTGAATTAACTGTTACAGTTGAAAGAA
IL1RAPL1-DMDchrX29417425chrX31697705616TTELTVTVERCTACTGAATTAACTGTTACAGTTGAAAGAA
IL1RAPL1-DMDchrX29417425chrX31697705716TELTVTVERCTGAATTAACTGTTACAGTTGAAAGAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
IL1RAPL1-DMDchrX29417425chrX316977051025TVTVERIQNQWDEVQCTGTTACAGTTGAAAGAATTCAGAATCAGTGGGATGAAGTACAAG
IL1RAPL1-DMDchrX29417425chrX31697705924LTVTVERIQNQWDEVTAACTGTTACAGTTGAAAGAATTCAGAATCAGTGGGATGAAGTAC

Top

Information of the samples that have these potential fusion neoantigens of IL1RAPL1-DMD

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
N/AIL1RAPL1-DMDchrX29417425ENST00000302196chrX31697705ENST00000343523AF533682

Top

Potential target of CAR-T therapy development for IL1RAPL1-DMD

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to IL1RAPL1-DMD

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to IL1RAPL1-DMD

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource